Iman Karimzadeh

3.1k total citations · 1 hit paper
100 papers, 2.1k citations indexed

About

Iman Karimzadeh is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Iman Karimzadeh has authored 100 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Pediatrics, Perinatology and Child Health and 17 papers in Pharmacology. Recurrent topics in Iman Karimzadeh's work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Pharmaceutical Practices and Patient Outcomes (15 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Iman Karimzadeh is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (15 papers), Pharmaceutical Practices and Patient Outcomes (15 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Iman Karimzadeh collaborates with scholars based in Iran, United States and Netherlands. Iman Karimzadeh's co-authors include Dorna Davani-Davari, Mostafa Seifan, Seyed Jalil Masoumi, Aydin Berenjian, Milad Mohkam, Younes Ghasemi, Manica Negahdaripour, Hossein Khalili, Mohammad Mahdi Sagheb and Simin Dashti‐Khavidaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and International Journal of Environmental Research and Public Health.

In The Last Decade

Iman Karimzadeh

90 papers receiving 2.1k citations

Hit Papers

Prebiotics: Definition, Types, Sources, Mechanisms, and C... 2019 2026 2021 2023 2019 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications
    2019 1.1k citations Dorna Davani-Davari, Iman Karimzadeh et al. profile →

Peers

Iman Karimzadeh
Jia Yin China
Thea Magrone Italy
João Felipe Mota Brazil
Hanne Rolighed Christensen Denmark
William B. Greenough United States
Natalia G. Vallianou Greece
Hanieh‐Sadat Ejtahed Iran
Iveta Garaiová United Kingdom
Ata Mahmoodpoor Iran
Annalisa Noce Italy
Jia Yin China
Iman Karimzadeh
Citations per year, relative to Iman Karimzadeh Iman Karimzadeh (= 1×) peers Jia Yin

Countries citing papers authored by Iman Karimzadeh

Since Specialization
Citations

This map shows the geographic impact of Iman Karimzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iman Karimzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iman Karimzadeh more than expected).

Fields of papers citing papers by Iman Karimzadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iman Karimzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iman Karimzadeh. The network helps show where Iman Karimzadeh may publish in the future.

Co-authorship network of co-authors of Iman Karimzadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Iman Karimzadeh. A scholar is included among the top collaborators of Iman Karimzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iman Karimzadeh. Iman Karimzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Karimzadeh, Iman, Mojtaba Shafiekhani, Reza Heidari, et al.. (2024). Protective effects of silymarin on preventing vancomycin nephrotoxicity in infectious patients: a randomized, double-blinded, placebo-controlled, pilot clinical trial. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(3). 2945–2960. 1 indexed citations
3.
4.
5.
Ahmadi, Hossein, et al.. (2024). Medication Reconciliation of Patients by Pharmacist at the Time of Admission and Discharge from Adult Nephrology Wards. SHILAP Revista de lepidopterología. 12(6). 170–170.
6.
7.
Gholami, Ahmad, Nima Montazeri‐Najafabady, Reza Heidari, et al.. (2023). The ameliorating effect of limosilactobacillus fermentum and its supernatant postbiotic on cisplatin-induced chronic kidney disease in an animal model. BMC Complementary Medicine and Therapies. 23(1). 243–243. 12 indexed citations
8.
Karimzadeh, Iman, et al.. (2023). Aminoglycosides: Single- or Multiple-daily Dosing? An Updated Qualitative Systematic Review of Randomized Trials on Toxicity and Efficacy. Current Molecular Medicine. 24(11). 1358–1373. 2 indexed citations
9.
Vazin, Afsaneh, et al.. (2022). Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations. Value in Health Regional Issues. 33. 99–108. 3 indexed citations
10.
Karimzadeh, Iman, et al.. (2020). Isotretinoin and the Kidney: Opportunities and Threats. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Ghasemiyeh, Parisa, Afshin Borhani‐Haghighi, Iman Karimzadeh, et al.. (2020). <p>Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review</p>. Therapeutics and Clinical Risk Management. Volume 16. 595–605. 37 indexed citations
12.
Shafiekhani, Mojtaba, et al.. (2020). Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial. SHILAP Revista de lepidopterología.
13.
Yaghoubi, Sajad, Meghdad Abdollahpour‐Alitappeh, Zahra Keshtkaran, et al.. (2020). Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review. Expert Opinion on Drug Safety. 19(2). 167–186. 48 indexed citations
14.
Karimzadeh, Iman, et al.. (2020). Acute lymphoblastic leukemia in children: A short review. SHILAP Revista de lepidopterología. 6(4). 283–296. 1 indexed citations
15.
Karimzadeh, Iman, Mahtab Jafari, Dorna Davani-Davari, & Mani Ramzi. (2020). The Pattern of Cyclosporine Nephrotoxicity and Urinary Kidney Injury Molecule 1 in Allogenic Hematopoietic Stem Cell Transplant Patients. Experimental and Clinical Transplantation. 19(6). 553–562. 6 indexed citations
16.
Karimzadeh, Iman, et al.. (2019). Medication reconciliation at admission by pharmacists in a teaching referral hospital in Iran. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Karimzadeh, Iman, et al.. (2019). <p>Pattern and associated factors of adherence to immunosuppressive medications in kidney transplant recipients at a referral center in Iran</p>. Patient Preference and Adherence. Volume 13. 729–738. 5 indexed citations
18.
Faridi, Pouya, et al.. (2018). Hot And Cold: An Old Theory With Modern Applications. SHILAP Revista de lepidopterología. 3 indexed citations
19.
Karimzadeh, Iman, et al.. (2016). Electrolyte disorders during vancomycin treatment in hospitalized patients at hematology-oncology wards of Namazi hospital in Shiraz. SHILAP Revista de lepidopterología. 2(3). 223–228. 2 indexed citations
20.
Karimzadeh, Iman, Hossein Khalili, & Mohammad Mahdi Sagheb. (2015). Preventing or attenuating amphotericin B nephrotoxicity with dopamine receptor agonists: a literature review. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jia Yin Breakdown of academic impact, for papers by Thea Magrone Breakdown of academic impact, for papers by João Felipe Mota Breakdown of academic impact, for papers by Hanne Rolighed Christensen Breakdown of academic impact, for papers by William B. Greenough Breakdown of academic impact, for papers by Natalia G. Vallianou Breakdown of academic impact, for papers by Hanieh‐Sadat Ejtahed Breakdown of academic impact, for papers by Iveta Garaiová Breakdown of academic impact, for papers by Ata Mahmoodpoor Breakdown of academic impact, for papers by Annalisa Noce
Rankless by CCL
2026